FRI0105 Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis

S.S. KOCA, B. Öz, A. Karatas, H.E. Dalkılıç, G. Can, Y. Pehlivan, S. Senel, A. Yazıcı, N. İnanç, A. Çefle, Z. Ertürk, S. Akar (+4 others)
2018 FRIDAY, 15 JUNE 2018   unpublished
Conclusions: in the future a version using multiple biomarkers could increase accuracy for identifying pretreatment patients who will respond to anti-TNF therapy. Smoking has a negative impact on the response to biologic treatment.
doi:10.1136/annrheumdis-2018-eular.5819 fatcat:gi22fbdjbrhm7oog7frozrihuu